Biotech billionaire Philip Frost agrees to proposed judgment in SEC case
December 28, 2018 at 12:21 PM EST
Dr. Philip Frost, the CEO and chairman of Opko Health and the former chairman of Teva, agreed to proposed settlement with the SEC on a civil case that the agency called $27 million "lucrative market manipulation schemes." Dr. Frost did not admit or deny the SEC's allegations.
